ASPMN Updates Guidelines on Monitoring for Opioid Induced Advancing Sedation and Respiratory Depression
Published January 24, 2020
“American Society for Pain Management Nursing Guidelines on Monitoring for Opioid Induced Advancing Sedation and Respiratory Depression: Revisions” was recently published in the Journal of Pain Management Nursing. The report provides updated evidence and revisions to the ASPMN 2011 guidelines for clinical decision-making for hospitalized adults receiving opioid analgesics.
The updated guidelines include refinement and more specific recommendations for electronic monitoring and present three risk factor categories.
UB SON Associate Professor Carla Jungquist, PhD, ANP-BC, FAAN, and Rosemary C. Polomano lead the 14-member expert panel, which reviewed and graded peer-reviewed scientific evidence, formulated recommendations and revised the guidelines.
Where to find the updated guidelines (article citation)
Jungquist, C. R., Quinlann-Colwell, A., Vallerand, A., Carlisle, H. L., Cooney, M., Dempsey, S. ... Polomano, R. C. (2020). American Society for Pain Management Nursing guidelines on monitoring for opioid-induced advancing sedation and respiratory depression: Revisions. Journal of Pain Management Nursing, 21(1), 7-25. https://doi.org/10.1016/j.pmn.2019.06.007
